| Item Type | Name |
|
Concept
|
Adolescent
|
|
Concept
|
Burkitt Lymphoma
|
|
Concept
|
Lymphoma
|
|
Concept
|
Lymphoma, B-Cell
|
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Young Adult
|
|
Academic Article
|
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
|
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
|
Academic Article
|
Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues.
|
|
Academic Article
|
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
|
|
Academic Article
|
The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.
|
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
|
|
Academic Article
|
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
|
|
Academic Article
|
The use of hypomethylating agents in the treatment of hematologic malignancies.
|
|
Academic Article
|
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
|
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
|
Academic Article
|
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
|
|
Academic Article
|
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
|
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
|
|
Academic Article
|
HMGA2 levels in CML: reflective of miRNA gene regulation in a hematopoietic tumor?
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells.
|
|
Academic Article
|
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
|
|
Academic Article
|
Getting to the root of the stem cell in mutated chronic myeloid leukemia.
|
|
Academic Article
|
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
|
|
Academic Article
|
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
|
|
Academic Article
|
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
|
|
Academic Article
|
Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
|
|
Academic Article
|
Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes.
|
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
|
Academic Article
|
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
|
|
Academic Article
|
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.
|
|
Academic Article
|
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.
|
|
Academic Article
|
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.
|
|
Academic Article
|
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
|
|
Academic Article
|
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
|
|
Academic Article
|
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
|
|
Academic Article
|
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
|
|
Academic Article
|
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.
|
|
Academic Article
|
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.
|
|
Academic Article
|
Genetic predisposition to leukemia and other hematologic malignancies.
|
|
Academic Article
|
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
|
|
Academic Article
|
Germline ETV6 mutations and predisposition to hematological malignancies.
|
|
Academic Article
|
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
|
|
Academic Article
|
Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
|
Academic Article
|
MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome.
|
|
Academic Article
|
Germline variants drive myelodysplastic syndrome in young adults.
|
|
Academic Article
|
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
|
|
Academic Article
|
RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.
|
|
Academic Article
|
Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites.
|
|
Academic Article
|
Anticipation in hematopoietic malignancies: biology, bias, or both?
|